Neuro42, Inc.
Medical device company · San Francisco, California, United States
Neuro42, Inc. is a medical device company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2024.
Neuro42 at a glance
What does Neuro42 do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2023 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $15.6 million sold (2024).
Frequently asked questions about Neuro42
Where is Neuro42 headquartered?
Neuro42, Inc. is headquartered in San Francisco, California, United States.
What does Neuro42 do?
Neuro42, Inc. is a medical device company.
When was Neuro42 founded?
The earliest incorporation on record for Neuro42, Inc. is in 2020, according to public company registers.
Similar companies
- Heartflow, Inc.San Francisco, California, United States
- iRhythm Holdings, Inc.San Francisco, California, United States
- Cytovale Inc.San Francisco, California, United States
- Posit Science CorpSan Francisco, California, United States
- Adynxx, Inc.San Francisco, California, United States
- Claria Medical, Inc.San Francisco, California, United States
- ReThink Medical, Inc.San Francisco, California, United States
- Teal Health IncSan Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences